Marco Ranzani

Disclosable Version of the ISR - Mauritius Statistical Capacity Building Project - P163248 - Sequence No : 01

Marco Ranzani, 2019 .

The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy.

Christof von Kalle, Alessandro Ambrosi, Luigi Naldini, 2009, The Journal of clinical investigation.

Cancer Gene Discovery: Exploiting Insertional Mutagenesis

David J. Adams, Eugenio Montini, Marco Ranzani, 2013, Molecular Cancer Research.

Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selection.

Gianluigi Zanetti, Christof von Kalle, Alessandra Biffi, 2011, Blood.

CopywriteR: DNA copy number detection from off-target sequence data

Jos Jonkers, Ekaterina Nevedomskaya, Bauke Ylstra, 2015, Genome Biology.

Lentiviral vector-based insertional mutagenesis identifies genes involved in the resistance to targeted anticancer therapies.

Andrea Calabria, Luigi Naldini, Fabrizio Benedicenti, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.